Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre Lestage

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
Farmaco (Societa Chimica Italiana : 1989)|November 8, 2002
Novel quinolinone-phosphonic acid AMPA antagonists devoid of nephrotoxicityAlex A Cordi, Patrice Desos, Elisabeth Ruano, et al.
Journal of Medicinal Chemistry|June 8, 2007
Design, synthesis, and pharmacology of novel 7-substituted 3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxides as positive allosteric modulators of AMPA receptorsPierre Francotte, Pascal de Tullio, Eric Goffin, et al.
Journal of Medicinal Chemistry|October 18, 2013
Synthesis, pharmacological and structural characterization, and thermodynamic aspects of GluA2-positive allosteric modulators with a 3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxide scaffoldAnn-Beth Nørholm, Pierre Francotte, Lars Olsen, et al.
Journal of Medicinal Chemistry|October 5, 2013
Development of thiophenic analogues of benzothiadiazine dioxides as new powerful potentiators of 2-amino-3-(3-hydroxy-5-methylisoxazol-4-yl)propionic acid (AMPA) receptorsPierre Francotte, Eric Goffin, Pierre Fraikin, et al.
Journal of Medicinal Chemistry|January 30, 2010
New fluorinated 1,2,4-benzothiadiazine 1,1-dioxides: discovery of an orally active cognitive enhancer acting through potentiation of the 2-amino-3-(3-hydroxy-5-methylisoxazol-4-yl)propionic acid receptorsPierre Francotte, Eric Goffin, Pierre Fraikin, et al.
ACS Chemical Neuroscience|July 9, 2021
Development of Thiochroman Dioxide Analogues of Benzothiadiazine Dioxides as New Positive Allosteric Modulators of α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid (AMPA) ReceptorsKoffi Sénam Etsè, Jerzy Dorosz, Katrine McLain Christensen, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 18, 2004
The serotonin1A receptor partial agonist S15535 [4-(benzodioxan-5-yl)1-(indan-2-yl)piperazine] enhances cholinergic transmission and cognitive function in rodents: a combined neurochemical and behavioral analysisMark J Millan, Alain Gobert, Sylvain Roux, et al.
European Journal of Pharmacology|March 19, 2017
In vivo pharmacological profile of S 38093, a novel histamine H3 receptor inverse agonistFany Panayi, Aurore Sors, Lionel Bert, et al.
European Journal of Pharmacology|March 25, 2017
Mechanistic characterization of S 38093, a novel inverse agonist at histamine H3 receptorsAurore Sors, Fany Panayi, Lionel Bert, et al.
Plos One|September 9, 2017
Pharmacological characterisation of S 47445, a novel positive allosteric modulator of AMPA receptorsSylvie Bretin, Caroline Louis, Laure Seguin, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Farmaco (Societa Chimica Italiana : 1989)|November 8, 2002
Novel quinolinone-phosphonic acid AMPA antagonists devoid of nephrotoxicityAlex A Cordi, Patrice Desos, Elisabeth Ruano, et al.
Journal of Medicinal Chemistry|June 8, 2007
Design, synthesis, and pharmacology of novel 7-substituted 3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxides as positive allosteric modulators of AMPA receptorsPierre Francotte, Pascal de Tullio, Eric Goffin, et al.
Journal of Medicinal Chemistry|October 18, 2013
Synthesis, pharmacological and structural characterization, and thermodynamic aspects of GluA2-positive allosteric modulators with a 3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxide scaffoldAnn-Beth Nørholm, Pierre Francotte, Lars Olsen, et al.
Journal of Medicinal Chemistry|October 5, 2013
Development of thiophenic analogues of benzothiadiazine dioxides as new powerful potentiators of 2-amino-3-(3-hydroxy-5-methylisoxazol-4-yl)propionic acid (AMPA) receptorsPierre Francotte, Eric Goffin, Pierre Fraikin, et al.
Journal of Medicinal Chemistry|January 30, 2010
New fluorinated 1,2,4-benzothiadiazine 1,1-dioxides: discovery of an orally active cognitive enhancer acting through potentiation of the 2-amino-3-(3-hydroxy-5-methylisoxazol-4-yl)propionic acid receptorsPierre Francotte, Eric Goffin, Pierre Fraikin, et al.
ACS Chemical Neuroscience|July 9, 2021
Development of Thiochroman Dioxide Analogues of Benzothiadiazine Dioxides as New Positive Allosteric Modulators of α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid (AMPA) ReceptorsKoffi Sénam Etsè, Jerzy Dorosz, Katrine McLain Christensen, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 18, 2004
The serotonin1A receptor partial agonist S15535 [4-(benzodioxan-5-yl)1-(indan-2-yl)piperazine] enhances cholinergic transmission and cognitive function in rodents: a combined neurochemical and behavioral analysisMark J Millan, Alain Gobert, Sylvain Roux, et al.
European Journal of Pharmacology|March 19, 2017
In vivo pharmacological profile of S 38093, a novel histamine H3 receptor inverse agonistFany Panayi, Aurore Sors, Lionel Bert, et al.
European Journal of Pharmacology|March 25, 2017
Mechanistic characterization of S 38093, a novel inverse agonist at histamine H3 receptorsAurore Sors, Fany Panayi, Lionel Bert, et al.
Plos One|September 9, 2017
Pharmacological characterisation of S 47445, a novel positive allosteric modulator of AMPA receptorsSylvie Bretin, Caroline Louis, Laure Seguin, et al.
Pageof 4